Clinical Trial Update: Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase I, open-label study evaluating autologous tumor-infiltrating lymphocytes engineered with membrane-bound IL-15 in adults with metastatic melanoma. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• Tumor infiltrating lymphocytes engineered with membrane-bound IL-15 (engineered tumor infiltrating lymphocytes with membrane-bound IL-15)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Tumor, Metastatic Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING